In several type of cancers, including lung cancer, the activation of WNT/β-catenin signaling in cancer cells has been associated with T cell deprivation in the tumor mass, low PD-L1 expression and resistance to immunotherapy (118–120). Here, CD274 is linked to neoplasm.